GlassScriptPhysician profile
Natasha Ghalib
NPI 1639672454
$14,369.08
in general payments reported to CMS, 2019-2025
12 companies · $619 in 2025
The $619 reported for 2025 was more than what 92% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $14K · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Food and Beverage: $632 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,500.00 |
| Food and Beverage | $631.91 |
| Education | $237.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,793.97 | 2024-2025 | Ensite, Assurity, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $170.86 | 2024-2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $106.50 | 2024-2025 | Farxiga, Wainua |
| Cleerly, INC. | $56.65 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Actelion Pharmaceuticals US, INC. | $53.80 | 2025 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $37.44 | 2024 | Arcalyst |
| Abiomed | $36.44 | 2024 | Impella |
| Scpharmaceuticals INC. | $34.51 | 2024 | |
| Bridgebio Pharma, INC. | $22.44 | 2025 | Attruby |
| Atricure, INC. | $20.67 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.15 | 2024 | |
| Novo Nordisk INC | $17.65 | 2025 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Ghalib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.